Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
Member count: 1-10
Founded date: 1999
Investors 1
| Date | Name | Website |
| - | Aphelion C... | aphelionca... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 11.05.2007 | StrataGent... | StrataGent Life Sciences, a Sa... | - | - | venturebea... |